Continuous glucose monitor data from patients on microdosing protocols shows improved time-in-range metrics even without significant weight loss
Retatrutide is an investigational triple receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors, producing more pronounced effects on appetite, insulin secretion, and energy expenditure than single or dual agonists
Interventions aimed at correcting metabolic imbalances, such as the use of antioxidants and metabolic regulators, may help improve outcomes in both diseases
Since these medications reduce your appetite, you will naturally consume fewer nutrients from food
We also offer intravenous glutathione administration in our office, where it is generally combined with a Modified Myers Cocktail, a form of intravenous micronutrient therapy